Cargando…
Deep Learning Segmentation of Triple-Negative Breast Cancer (TNBC) Patient Derived Tumor Xenograft (PDX) and Sensitivity of Radiomic Pipeline to Tumor Probability Boundary
SIMPLE SUMMARY: Co-clinical trials are an emerging area of investigation in which a clinical trial is coupled with a corresponding preclinical trial to inform the corresponding clinical trial. The preclinical arm aids in assessing therapeutic efficacy, patient stratification, and designing optimal i...
Autores principales: | Dutta, Kaushik, Roy, Sudipta, Whitehead, Timothy Daniel, Luo, Jingqin, Jha, Abhinav Kumar, Li, Shunqiang, Quirk, James Dennis, Shoghi, Kooresh Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345151/ https://www.ncbi.nlm.nih.gov/pubmed/34359696 http://dx.doi.org/10.3390/cancers13153795 |
Ejemplares similares
-
Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging
por: Roy, Sudipta, et al.
Publicado: (2020) -
Test–Retest Performance of a 1-Hour Multiparametric MR Image Acquisition Pipeline With Orthotopic Triple-Negative Breast Cancer Patient-Derived Tumor Xenografts
por: Ge, Xia, et al.
Publicado: (2019) -
Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021) -
Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021) -
Patient-derived xenograft (PDX) tumors increase growth rate with time
por: Pearson, Alexander T., et al.
Publicado: (2016)